1Stahl S, Zivkov M, Reimitz PE, Panaqides J. Hoff W. Meta-analysis of randomized, double-blind, placebo-controlled. efficacy and safety studies of mirtazapine versus amitriptyline in major depression[J]. Acta psychiatry Scand Suppl, 1997, 391:22.
2Stimmel GL, Dopheide JA. Mirtazapine: an antidepressant with noradrenerqic and specific serotonerqic effects[J]. Pharmacotherapy. 1997, 17:10.
3Fawcett J, Barkin RL. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety[J]. J Clin Psychiatry. 1998.59:123.
4Owens MJ. Knight DL. Nemeroff CB. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine [J]. Biol Psychiatry,2001,50:345.
5Monzgomery SA. Loft H. Sanchez C. Reines EH .Papp M. Escitalopram (S-enantiomer of citalopram ) : clinical efficacy and onset of action predicted from a rat mode[J]. Pharmacol Toxicol, 2001,88:282.
6Burke WJ. Gergel I. Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients[J].J Clin Psychiatry, 2002,63:331.
7Wade A, Michael Lemming O, Bang Hedegaard K.Esckalopram 10mg/day is effective and well tolerated in a place-controlled study in depression in primary care[J]. Int Clin Psychopharmacol, 2002. 17:95.
8Wond EH. Sonders MS. Amara SG, et al. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake[J]. Biol Psychiatry. 2000.47: 818.
9Academic highlights. The medicine., current treatment advances in depression[J]. J Clin Psychiatry, 2001, 62(5) : 382.
10Versiani M. Mehilane L, Gaszner P et al. reboxezine. a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder[J]. J Clin Psychiatry, 1999, 60(6) :400.
5[5]Thase ME.Antidepressant treatment of the depressed patient with insomnia[J].J Clin Psychiatry,1999,60(Suppl 17)∶S28-S31.
6[6]Gelenberg AJ,Laukes C,Mcgahey C,et al.Mirtazapine substitution in SSRI-induced sexual dysfunction[abstract][J].J Bio Psychiatry,1998,43∶104s.
7[7]Wheatly DP,Van Moffaertm,Timmermanl,et al.Mirtazapine:efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder[J].J Clin Psychiatry,1998,59∶306-312.
